Final Round Player 😷🇪🇺🍸

The JCVI really is not fit for purpose.
https://www.gov.uk/government/publications/covid-19-vaccination-in-2025-and-spring-2026-jcvi-advice/jcvi-statement-on-covid-19-vaccination-in-2025-and-spring-2026

Can you count the errors in that intro?
- naturally acquired immunity
- a relatively mild disease for most people
- As COVID-19 becomes an endemic disease
- the oldest in the population being the most vulnerable

Disband the JCVI and start again. They're lying to us, and with-holding the vax.

JCVI statement on COVID-19 vaccination in 2025 and spring 2026

GOV.UK
Nov 14, 2024 at 11:31amWeb
Show threadFinal Round Player 😷🇪🇺🍸Nov 14, 2024

It looks very much like they're back to this limited subset for Spring 75 and onwards. No HCW. No Under 75. No Pregnant mums.

>
- adults aged 75 years and over
- residents in a care home for older adults
- individuals aged 6 months and over who are immunosuppressed (as defined in the ‘immunosuppression’ sections of tables 3 or 4 in the COVID-19 chapter of the Green Book)

Show threadFinal Round Player 😷🇪🇺🍸Nov 14, 2024
Why would you continue to accept a Joint Committee on Vaccination and Immunisation consisting of anti-vax people. And pursue a Vaccine Only strategy of Covid mitigation where you don't actually give the vax to anyone.
Show threadMarjorieRNov 14, 2024

@jbond they give the game away with the first line in the Report:

"The aim of the COVID-19 immunisation programme is to prevent serious disease (hospitalisation and/or mortality) arising from COVID-19."

So no thought of the increased risk of getting Long Covid with all that implies for economic participation from repeat infections or the continuing costs to individuals and the economy of infections, even of some of them are mild.

Of course wider treatment might not be cost effective but it would be sensible to at least do the sums.

Show threadMarjorieRNov 15, 2024
@jbond noting they also discuss the cost of the vaccine and administering it, to the NHS as this obviously drives the cost side of the cost benefit analysis.
They all about a cost of £25 per dose, plus about £10 to administering it, which is the sort of price that a big customer like the NHS ought to be able to get.
However although you can buy a Covid vaccine shot yourself the cost is currently nearer £100.
Surely it would be cost effective for the government to offer to buy a larger inventory of vaccine and make it available to the wider public for £35 rather than the £100 at which it is currently on offer?
Let the curetly ineligible public decide whether at that sort of price it's worth it: obviously not everyone will - currently the take up in the 70+, who can get ift for free, is only about 40%.
Show threadFinal Round Player 😷🇪🇺🍸Nov 15, 2024
@marjolica And noting that the MHRA still hasn't approved JN.1 Novavax so you can't get that privately. Which protects Pfizer's profits as its 1/4 of the price.